Navigation Links
Lilly Provides Its Perspective in Response to Amylin Lawsuit
Date:5/16/2011

INDIANAPOLIS, May 16, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California. The lawsuit alleges that Lilly is not using commercially reasonable efforts to support the success of BYETTA® (exenatide injection) and ultimately, BYDUREON™ (exenatide extended-release for injectable suspension).

"We emphatically reject the allegation that we did not meet our contractual obligations under the Lilly and Amylin alliance," said Enrique Conterno, president of Lilly Diabetes. "Lilly has been and remains fully committed to fulfilling its obligations under its exenatide collaboration agreement with Amylin as well as to complying with all laws and regulations."

More options for patients – Given that diabetes is a complex and chronic condition, patients and their health care providers need choices throughout the progression of the disease. Our strategy in Lilly Diabetes is to offer a broad range of treatment options.

Our pursuit of this strategy through collaborations with partners such as Amylin and Boehringer Ingelheim allows us to educate physicians more effectively and efficiently about a broad range of treatment options. Contrary to the suggestions in Amylin's complaint, Lilly's actions encourage competition and benefit diabetes patients for whom there is significant unmet need today.

Regarding BYETTA and Tradjenta™ (linagliptin) tablets, our broad market experience teaches us that injectables like BYETTA generally compete with other injectable treatments in the class rather than with oral anti-diabetic agents.

No breach of contract – The Lilly and Amylin alliance contract specifically provides for Lilly's ability to develop and market a full ran
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  A prospective ... Sweden has validated the performance ... platforms and has associated volumetrically assessed breast density ... Cancer Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), ... a tool for widespread breast cancer risk assessment," ...
(Date:7/28/2014)... 28, 2014  ALPHAEON Corporation ® ... and subsidiary of Strathspey Crown Holdings ... Nutriceuticals (PRN) ® , a leading developer ... for dry eye and macular degeneration, ... worth up to $55M. ...
(Date:7/28/2014)... 2014 OmPrompt gab ... £ investiert hat, um die weltweite Nachfrage ... und Logistikbranche zu erfüllen. Albion wird Teil ... http://photos.prnewswire.com/prnh/20140728/697982 ) In ... beschleunigtes Wachstum mit Investitionen in seine Plattform, ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3OmPrompt erhält Finanzierung für Marktexpansion von Kundenautomatisierungsmanagement 2
... Va., Oct. 1 Today, PARI Respiratory Equipment introduced the ... can be used with all PARI LC reusable nebulizers. ... with nebulizer therapies for airway clearance and lung strengthening exercises ... PEP S is an incredible new device that improves patient ...
... WOODLAND HILLS, Calif., Oct. 1 In a continued ... forefront, Anthem Blue Cross, State Sponsored Business launched an ... a virtual BMI wheel and web-based interactive practice sessions ... launch of the online BMI training program builds on ...
Cached Medicine Technology:PARI Respiratory Launches PEP S 2Anthem Blue Cross Takes BMI Training Virtual with New Online Capability 2Anthem Blue Cross Takes BMI Training Virtual with New Online Capability 3
(Date:7/28/2014)... (PRWEB) July 28, 2014 A January ... reduction of gluten intake in those who were self-diagnosed ... Mittry, director of nutrition for San Diego health and ... various gluten considerations for those who are unclear about ... explains that gluten is a protein, found in wheat, ...
(Date:7/28/2014)... By Randy Dotinga ... -- Scientists know it takes humans just milliseconds to look ... Now, a new study finds that certain facial features ... too. The shape and size of the mouth, for ... eye dimensions are keys to attractiveness. The study ...
(Date:7/28/2014)... Shofner Vision Center recently wrapped ... Renowned LASIK and Cataract Surgeon, Dr. Stewart Shofner ... and public awareness for local not-for-profit organizations that ... their families. “This was our 2nd annual summer ... to a variety of local not-for-profit organizations who ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) --,The more chronic medical ... life expectancy may be, a new study claims. ... multiple health issues, scientists at Johns Hopkins Bloomberg School ... help explain why gains in life expectancy are slowing ... diseases such as diabetes, kidney disease and heart failure ...
(Date:7/28/2014)... SIMpalm helped its client to launch ... on iTunes for download . Experience a new way ... you to listen and cook along with expert real-time audio ... out the ingredients and equipment, press play, and follow the ... ahead of time, just relax and cook along with us. ...
Breaking Medicine News(10 mins):Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 2Health News:VeraVia Explains the Basics of Gluten-Intolerance Following Industry Study 3Health News:Facial Dimensions May Be Key to First Impressions 2Health News:Facial Dimensions May Be Key to First Impressions 3Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 2Health News:Shofner Vision Center’s “Operation Military June” Provided Funds For Local Not-For-Profit Organizations Supporting Military And Their Families 3Health News:Chronic Medical Conditions Can Shorten Seniors' Lives: Study 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 2Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 3Health News:Audio Chef Co. Releases Audio Cooking App for iPhone/iPad/iPod touch 4
... Health IT Now! Coalition applauds the House,s important decision ... in the American Recovery and Reinvestment Act for incentives ... thrilled by this outcome," Joel White, executive director of ... half the coalition has advocated for legislation with significant ...
... found that exercise may be a factor in recovering ... TKA) and knee osteoarthritis (OA). One study involving a ... that it enhanced clinical improvement almost to the level ... to examine the relationship between four components of physical ...
... RALEIGH, N.C., Jan. 29 North State Bancorp (OTC,Bulletin ... State,Bank, reported total assets of $687.6 million as of ... at December 31, 2007, an increase,of $140.1 million or ... North State Bank at December 31, 2008 were $612.7,million ...
... LANSING, Mich., Jan. 29 Julie L. Novak has ... State Medical Society (MSMS) effective immediately, the MSMS Board ... the past year as MSMS Acting Executive Director, succeeds ... a year-long illness. Kelly served 29 years at ...
... Caraco Pharmaceutical,Laboratories, Ltd. (NYSE Alternext US: CPD) posted ... and first nine months of Fiscal 2009 of $55.7,million ... and,$158.6 million, respectively, for the third quarter and first ... in the third quarter of Fiscal 2009,and an increase ...
... Disease Management Funding a Major Step ForwardWASHINGTON, Jan. ... (PFCD) today lauded the U.S. House of Representatives ... in the economic stimulus package. "Keeping Americans ... recovery plan," said Ken Thorpe, Ph.D., Executive Director ...
Cached Medicine News:Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 2Health News:Exercise plays large role in recovery from knee replacement and the occurrence of osteoarthritis 3Health News:North State Bancorp Reports Profitable 2008 2Health News:North State Bancorp Reports Profitable 2008 3Health News:North State Bancorp Reports Profitable 2008 4Health News:North State Bancorp Reports Profitable 2008 5Health News:North State Bancorp Reports Profitable 2008 6Health News:Julie L. Novak Named Executive Director of Michigan State Medical Society 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 2Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 3Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 4Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 5Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 6Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 7Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 8Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 9Health News:Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009 10Health News:National Health Care Coalition Commends New Congress' Focus on Fighting Chronic Disease in House Stimulus Package 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: